1. ALLA AKTIER
  2. NYHETER
  3. ASARINA PHARMA

Asarina Pharma

Nyheter Asarina Pharma Nyheter alla bolag

Asarina Pharma AB (publ) shares to be delisted and the last day of trading is 1 October 2024

MARKN.

Asarina Pharma AB (publ) ("Asarina" or the "Company") announced on 13 September 2024 that the Company has applied for the delisting of its shares from Nasdaq First North Growth Market in Stockholm. Nasdaq Stockholm has approved the Company's application for delisting.

The board of Asarina decided on 13 September 2024 to apply for the delisting of the Company's shares from the Nasdaq First North Growth Market in Stockholm. According to a decision from Nasdaq Stockholm, Asarina's shares will be delisted from the Nasdaq First North Growth Market. The last day of trading in the Company's shares will be 1 October 2024.

For further information, please contact:
Peter Nordkild, CEO
Tel.: +45 25 47 16 46
Email: peter.nordkild@asarinapharma.com
 

About Asarina Pharma
Asarina Pharma AB (publ) is a Swedish biotechnology company. The company was founded in 2006 and the share has been traded since September 2018 on the Nasdaq First North Growth Market. Asarina Pharma AB (publ) is based in Solna. Asarina Pharma AB (publ) is listed on the Nasdaq First North Growth Market. The company thus follows the regulations that apply to First North. The company's Certified Adviser is Carnegie Investment Bank AB (publ).
 
For further information see our website: www.asarinapharma.se.

Attachments
Asarina Pharma AB (publ) shares to be delisted and the last day of trading is 1 October 2024

Datum 2024-09-16, kl 20:00
Källa MFN
Bifogade filer
Asarina Pharma AB (publ) shares to be delisted and the last day of trading is 1 October 2024
Affiliate
Skapa konto direkt med BankID hos Skilling så får du tillgång till tusentals finansmarknader inom valuta, aktier, krypto och mycket mer. Välj bland 1200+ CFD-instrument över 7 tillgångsklasser till konkurrenskraftiga priser. Skilling erbjuder också en kapitalförsäkring.
CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.